Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Ravandi, Farhad"'
Autor:
Abuasab T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Masarova L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Patel K; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bose P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Villarreal J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., DiNardo C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Verstovsek S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Jul; Vol. 99 (7), pp. 1434-1436. Date of Electronic Publication: 2024 Apr 13.
Autor:
Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, USA. Electronic address: GMontalban1@mdanderson.org., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, USA., Chien K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, USA., Hammond D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, USA., Short N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, USA., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, USA., Kanagal-Shammana R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, USA., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, USA., Qiao W; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, USA., Huang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, USA., Schneider H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, USA., Meyer M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, USA., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, USA.
Publikováno v:
Leukemia research [Leuk Res] 2024 Jul; Vol. 142, pp. 107518. Date of Electronic Publication: 2024 May 11.
Autor:
Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. GMontalban1@mdanderson.org., Rodriguez-Sevilla JJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Swanson DM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hammond D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chien K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., DiNardo C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Short N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bueso-Ramos C; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Leukemia [Leukemia] 2024 May; Vol. 38 (5), pp. 1178-1181. Date of Electronic Publication: 2024 Feb 28.
Autor:
Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Dinardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Nasr LF; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Macaron W; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Nasnas C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Huang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX., Qiao W; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX., Matthews J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Stojanik CJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Abramova R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Thankachan J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 May 01; Vol. 42 (13), pp. 1499-1508. Date of Electronic Publication: 2024 Jan 26.
Autor:
Tanaka T; Department of Leukemia., Morita K; Department of Leukemia., Loghavi S; Department of Hematopathology, and., Wang F; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Furudate K; Department of Leukemia.; Department of Oral and Maxillofacial Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan; and., Sasaki Y; Department of Leukemia., Little L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Gumbs C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Matthews J; Department of Leukemia., Daver N; Department of Leukemia., Pemmaraju N; Department of Leukemia., DiNardo CD; Department of Leukemia., Sasaki K; Department of Leukemia., Yilmaz M; Department of Leukemia., Kadia TM; Department of Leukemia., Ravandi F; Department of Leukemia., Konopleva MY; Department of Leukemia., Kantarjian HM; Department of Leukemia., Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Al-Atrash G; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Garcia-Manero G; Department of Leukemia., Wang SA; Department of Hematopathology, and., Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Takahashi K; Department of Leukemia.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Blood [Blood] 2021 Nov 04; Vol. 138 (18), pp. 1733-1739.
Autor:
Loghavi S; The Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, USA., DiNardo CD; The Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA., Furudate K; The Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA.; Department of Oral and Maxillofacial Surgery, Hirosaki University Graduate School of Medicine, Aomori, Japan., Takahashi K; The Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA., Tanaka T; The Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA., Short NJ; The Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA., Kadia T; The Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA., Konopleva M; The Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA., Kanagal-Shamanna R; The Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, USA., Farnoud NR; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Pierce S; The Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA., Khoury JD; The Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, USA., Jorgensen JL; The Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, USA., Patel KP; The Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, USA., Daver N; The Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA., Yilmaz M; The Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA., Medeiros LJ; The Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, USA., Kantarjian H; The Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA., Ravandi F; The Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA., Wang SA; The Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2021 Mar; Vol. 192 (6), pp. 1054-1063. Date of Electronic Publication: 2021 Feb 22.
Autor:
Alfayez M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang F; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cortes JE; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Assi R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lebanese American University and Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. GBorthak@mdanderson.org.
Publikováno v:
Leukemia [Leukemia] 2021 Mar; Vol. 35 (3), pp. 691-700. Date of Electronic Publication: 2020 Jun 19.
Autor:
Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Guerra V; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ramos-Perez J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hammond D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Shilpa P; Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Naqvi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., DiNardo C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Estrov Z; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Khoury JD; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bueso-Ramos C; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Patel K; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2021 Feb 01; Vol. 96 (2), pp. E50-E53. Date of Electronic Publication: 2020 Nov 21.
Autor:
Shoukier M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Alotaibi AS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Alfayez M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Cortes J; Georgia Cancer Center at Augusta University, Augusta, Georgia., Samra B; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Masarova L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Cancer [Cancer] 2021 Feb 01; Vol. 127 (3), pp. 381-390. Date of Electronic Publication: 2020 Oct 29.
Autor:
Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Section of Molecular Hematology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zeng Z; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Section of Molecular Hematology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Cortes JE; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Chen HC; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Huang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Section of Molecular Hematology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kelly MA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., McQueen T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Section of Molecular Hematology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang RY; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Section of Molecular Hematology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Andreeff M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Section of Molecular Hematology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
American journal of hematology [Am J Hematol] 2020 Nov; Vol. 95 (11), pp. 1296-1303. Date of Electronic Publication: 2020 Aug 19.